About: Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article by Mirjam Christ-Crain et al published July 2006 in American Journal of Respiratory and Critical Care Medicine

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в липні 2006 (uk) im Juli 2006 veröffentlichter wissenschaftlicher Artikel (de) scholarly article by Mirjam Christ-Crain et al published July 2006 in American Journal of Respiratory and Critical Care Medicine (en)
publication date	wds:Q55966607-269F8C7E-7D8C-4FA4-B97A-5204C90D0F8B
publication date	2006-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q55966607-972FCBB0-5E02-47E0-B54F-7E464CFD301C
language of work or name	English
cites work	wds:Q55966607-0077C2A5-B8EC-45C0-9AF9-0EED1F11B77A wds:Q55966607-0096887C-D04D-4A42-A45D-253142196A40 wds:Q55966607-0134B414-7634-4193-A092-27301864F067 wds:Q55966607-0B2B1BB2-DD01-45A7-A1C4-F1FF2C3D6233 wds:Q55966607-0CC53C18-87F8-4E99-BE65-76085FD94688 wds:Q55966607-0D476FFA-EF38-430C-9CDD-9448F2C8AD6F wds:Q55966607-0DB22BE7-734D-44AF-A819-C4E7EF2AC5C1 wds:Q55966607-1E6CB58A-1F8A-4246-815B-4562B1B54F63 wds:Q55966607-1EA5947D-EB34-4935-B1C9-788FE9642AF1 wds:Q55966607-1F4E759B-0BF4-43E0-B47A-03FC30B62B57 wds:Q55966607-22FF11E4-1D00-470B-A4EE-E1488969305B wds:Q55966607-28A7B68D-EC14-4F60-B27C-F85420952F4A wds:Q55966607-3474D44B-C1A7-4E0E-AE05-CC9E1C491320 wds:Q55966607-3A1EF863-6DCF-4212-BDCB-58955739919B wds:Q55966607-4263AEC3-520C-4CBE-ACA1-3500E2A9F7AC wds:Q55966607-52265A24-931D-4812-AC41-1A337BC66D8B wds:Q55966607-648C0443-7B3A-4703-9A71-DEC394838588 wds:Q55966607-6FD93D1A-9483-46A9-BCBF-142D2D319811 wds:Q55966607-7AFC7107-FF3E-46E0-974C-7FBA4D8601E8 wds:Q55966607-8C65A874-E446-4EE1-86A2-B5727DBA5A72 wds:Q55966607-92C9F3AF-6EBA-4C4D-86A8-CFD3199954FB wds:Q55966607-962B286B-30CF-4164-B0B5-049BB5FFF96B wds:Q55966607-9ACC81DC-13BA-4142-B081-6C1A504F111F wds:Q55966607-9BBBF08C-8A42-4178-895C-FF2BDF942435 wds:Q55966607-9C1B57DA-E9EF-44F4-AD42-A76A01976A9E wds:Q55966607-9CC1D906-1272-4A07-B9F3-F3A83E13F4B4 wds:Q55966607-9D3F9DCE-80B5-41BD-AAD0-85574A0AD9E7 wds:Q55966607-BCF7F9C4-AD54-45EA-BD6A-A2D7F9191A3B wds:Q55966607-BF9BF98E-ABD3-40F8-A90A-38176C10EFD8 wds:Q55966607-C1151D60-D178-4259-9F03-CDAFEF789393 wds:Q55966607-C70AA0C7-6444-4700-BD4D-D28A0751AE21 wds:Q55966607-C89CC3CA-4343-4434-B5D2-419D40D56DF1 wds:Q55966607-C9BF3C6A-CE64-43FB-8F05-E9C1AB8B819F wds:Q55966607-CFAEECFD-10F3-4BC0-AC94-C699B08307D0 wds:Q55966607-D303F652-5CC9-4682-A062-CA477138E66E wds:Q55966607-D5DA6D5D-7FD4-48C2-A645-B1FCFD00D755 wds:Q55966607-EABB9DE8-5826-4C70-965F-B7C029D05FC8 wds:Q55966607-F3D51BBF-8DFB-4F8B-AD20-40B112DF948D wds:Q55966607-FF528C9D-AE85-47CF-AB02-7E17938C4507
cites work	Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study Quality of care, process, and outcomes in elderly patients with pneumonia Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors Trends in antimicrobial drug prescribing among office-based physicians in the United States. Diagnosing pneumonia by physical examination: relevant or relic? Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients The revised CONSORT statement for reporting randomized trials: explanation and elaboration wd:Q24815302 Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. A prediction rule to identify low-risk patients with community-acquired pneumonia Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Toward a consensus definition for COPD exacerbations Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis Clinical practice. Management of community-acquired pneumonia Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis Pneumonia in the very old Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials The future diagnostic role of procalcitonin levels: the need for improved sensitivity Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Guidelines for the Treatment of Community-acquired Pneumonia How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia Short-course treatment of community-acquired pneumonia. What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia? Procalcitonin and ventilator-associated pneumonia: yet another breath of fresh air. Preventing the risk of emergence of bacterial resistance associated with antibiotic therapy: what role for pharmacokinetic and pharmacodynamic data?
author name string	wds:Q55966607-29FE52A4-148C-401C-A400-C7E3D72CE53B wds:Q55966607-35685B25-74D0-4480-9933-B094C9B911F2 wds:Q55966607-8CD2EC6C-60D5-4637-BDDC-B4889B153A66 wds:Q55966607-C05B83EA-2E15-4D57-AF7F-6DA7AF5887E8 wds:Q55966607-F23646CB-F919-4617-BE2B-3C0BD3504866 wds:Q55966607-F7DA4046-8EE2-44A4-B71F-EE18B583045F wds:Q55966607-FE3F0BE1-50B8-45D7-B872-A91071B4374C
author name string	Christian Müller Beat Müller Daiana Stolz Michael Tamm Werner Zimmerli

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software